文献速递神经肿瘤

经蝶窦垂体腺瘤切除术中重叠手术的并发症与费用评估

Evaluation of Complications and Costs During Overlapping Transsphenoidal Surgery in the Treatment of Pituitary Adenoma.
PubMed 文献 · Neurosurgery · 2019-01-01

单中心回顾性队列研究纳入629例经蝶窦垂体腺瘤切除术患者(非重叠302例、重叠327例),比较两组并发症与费用。作者认为重叠手术未导致并发症加重、手术时间延长或费用增加。

要点

  • 重叠手术组与非重叠手术组并发症率相当(P=.6),总费用与亚总费用均无差异。
  • 两组全切除率(P=.9)、复发率(P=.4)、手术时间(P=.4)均无显著差异。
  • 作者认为改善患者安全与费用的研究应聚焦医疗服务的其他方面。

核心结论

  • 重叠手术未导致经蝶窦垂体腺瘤切除术患者并发症加重、手术时间延长或费用增加。

研究设计与样本

  • 单中心回顾性队列研究,共纳入629例经蝶窦入路垂体腺瘤切除术患者,其中非重叠手术302例、重叠手术327例,分析患者、手术、并发症及费用(价值驱动结局)变量。

主要发现

  • 两组年龄(P=.6)、性别(P=.5)、肿瘤类型(P=.5)、既往垂体腺瘤切除率(P=.5)均无显著差异。
  • 两组就诊症状相似,随访时长相当(P=.3)。
  • 两组肿瘤大小(P=.5)、手术时间(P=.4)、脂肪/筋膜使用(P=.4)、脑脊液分流(P=.8)均无差异。
  • 全切除率无显著差异(P=.9),复发率无差异(P=.4),并发症率相当(P=.6)。
  • 总费用与亚总费用均无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pituitary adenomas are among the most common primary brain tumors. Recently, overlapping surgery has been curbed in many institutions because of the suggestion there might be more significant adverse events, despite several studies showing that complication rates are equivalent. OBJECTIVE: To assess complications and costs associated with overlapping surgery during the transsphenoidal resection of pituitary adenomas. METHODS: A single-center, retrospective cohort study was performed to evaluate the cases of patients who underwent a transsphenoidal approach for pituitary tumor resection. Patient, surgical, complication, and cost (value-driven outcome) variables were analyzed. RESULTS: A total of 629 patients (302 nonoverlapping, 327 overlapping cases) were identified. No significant differences in age (P = .6), sex (P = .5), tumor type (P = .5), or prior rates of pituitary adenoma resection (P = .5) were seen. Similar presenting symptoms were observed in the 2 groups, and follow-up length was comparable (P = .3). No differences in tumor sizes (P = .5), operative time (P = .4), fat/fascia use (P = .4), or cerebrospinal fluid diversion (P = .8) were seen between groups. The gross total resection rate was not significantly different (P = .9), and no difference in recurrence rate was seen (P = .4). A comparable complication rate was seen between groups (P = .6). No differences in total or subtotal costs were seen either. CONCLUSION: The results of this study offer additional evidence that overlapping surgery does not result in worsened complications, lengthened surgery, or increased patient cost for patients undergoing transsphenoidal resection of pituitary adenomas. Thus, studies and policy aiming to improve patient safety and cost should focus on optimizing other aspects of healthcare delivery.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Karsy M, Bowers CA, Scoville J, et al. Evaluation of Complications and Costs During Overlapping Transsphenoidal Surgery in the Treatment of Pituitary Adenoma. Neurosurgery. 2019. PMID: 29897572. doi:10.1093/neuros/nyy269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。